Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats
✍ Scribed by Sozański, Tomasz; Magdalan, Jan; Trocha, Małgorzata; Szumny, Antoni; Merwid-Ląd, Anna; Słupski, Wojciech; Karaźniewicz-Łada, Marta; Kiełbowicz, Grzegorz; Ksiądzyna, Dorota; Szeląg, Adam
- Book ID
- 122158641
- Publisher
- Elsevier
- Year
- 2011
- Tongue
- English
- Weight
- 222 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1734-1140
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The changes in pharmacokinetics of DA‐8159 by omeprazole with respect to inhibition of CYP3A1/2 in rats were evaluated. After oral administration of DA‐8159 at dose of 30 mg/kg to rats pretreated with oral omeprazole at 30 mg/kg for 1 week, the total area under the plasma concentration–
The effect of omeprazole on oral and intravenous (iv) RS-methadone pharmacokinetics and pharmacodynamics was studied in awake, freely moving rats, which were divided in four groups: oral RS-methadone (3 mg/kg) was given (a) to a control group (CO(oral)) (n = 65) and (b) to an omeprazole pretreated g